{"filing":{"accession_number":"0001493152-26-043919","cik":"0001618835","ticker":"EVFM","company_name":"Evofem Biosciences, Inc.","form":"8-K","filing_date":"2026-09-23","report_date":"2026-09-17","primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1618835/000149315226043919/form8-k.htm"},"events":[{"id":34574,"run_id":31819,"accession_number":"0001493152-26-043919","anchor_item_number":"1.01","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"summary":"Evofem entered into a Manufacturing Agreement with Zhaoke to become a second manufacturer and supplier of PHEXX®. This is a material operational and strategic event—adding manufacturing capacity, improving supply chain flexibility, and reducing unit costs by 40% or more—but it does not constitute a merger, acquisition, disposition, or change of control (ma_activity). The agreement is a material supply/manufacturing contract that supports the company's growth strategy and is best classified as an operational event rather than a financial or governance matter.","company_name":"Evofem Biosciences, Inc.","ticker":"EVFM","filing_date":"2026-09-23","form":"8-K","submitted_at":null,"items":[{"id":38332,"accession_number":"0001493152-26-043919","item_number":"1.01","item_title":"Entry into","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"Evofem entered into a Manufacturing Agreement with Zhaoke to become a second manufacturer and supplier of PHEXX®. This is a material operational and strategic event—adding manufacturing capacity, improving supply chain flexibility, and reducing unit costs by 40% or more—but it does not constitute a merger, acquisition, disposition, or change of control (ma_activity). The agreement is a material supply/manufacturing contract that supports the company's growth strategy and is best classified as an operational event rather than a financial or governance matter.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-23T20:09:19.918446+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":38332,"accession_number":"0001493152-26-043919","item_number":"1.01","item_title":"Entry into","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"Evofem entered into a Manufacturing Agreement with Zhaoke to become a second manufacturer and supplier of PHEXX®. This is a material operational and strategic event—adding manufacturing capacity, improving supply chain flexibility, and reducing unit costs by 40% or more—but it does not constitute a merger, acquisition, disposition, or change of control (ma_activity). The agreement is a material supply/manufacturing contract that supports the company's growth strategy and is best classified as an operational event rather than a financial or governance matter.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-23T20:09:19.918446+00:00","company_name":"Evofem Biosciences, Inc.","ticker":"EVFM","filing_date":"2026-09-23"}]}